James Collins

James Collins

Director/Board Member presso SENTI BIOSCIENCES, INC.

Patrimonio netto: 288 911 $ in data 31/03/2024

58 anni
Health Technology
Commercial Services
Consumer Services

Profilo

James J.
Collins
is the founder of Cellicon Biotechnologies, Inc. (founded in 2000), Corvium, Inc. (founded in 2009), Synlogic Operating Co., Inc. (founded in 2014), EnBiotix, Inc. (founded in 2012), Senti Sub I, Inc. (founded in 2016), Synlogic, Inc. (founded in 2017), Sherlock Biosciences, Inc. (founded in 2018), and Cellarity Inc. (founded in 2017).
He currently holds the position of Independent Director at Fulcrum Therapeutics, Inc. (since 2017), Independent Director at Orion Biotech Opportunities Corp., Independent Director at Senti Biosciences, Inc. (since 2022), Professor at Harvard University, Professor at Massachusetts Institute of Technology (since 2014), and Member of the National Academy of Sciences, American Academy of Arts & Sciences, National Academy of Engineering, National Academy of Medicine (United States), Excel Medical Ventures LLC (Board of Strategic Advisors), The Broad Institute, Inc., Harvard Mit Health Sciences & Technology, and National Academy of Inventors.
He previously held the position of Chief Scientific Officer at Aitia, Inc. (from 2008 to 2012) and Professor at Boston University (from 1990 to 2014).
He completed his undergraduate degree at the College of the Holy Cross (Massachusetts) and obtained a doctorate degree from the University of Oxford.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
27/06/2023 23 571 ( 0.04% ) 222 510 $ 31/03/2024
16/06/2023 176 130 ( 0.38% ) 66 401 $ 31/03/2024

Posizioni attive di James Collins

SocietàPosizioneInizio
ORION BIOTECH OPPORTUNITIES CORP. Director/Board Member -
FULCRUM THERAPEUTICS, INC. Director/Board Member 01/01/2017
SENTI BIOSCIENCES, INC. Director/Board Member 08/06/2022
Massachusetts Institute of Technology Corporate Officer/Principal 01/12/2014
Corporate Officer/Principal -
Director/Board Member -
Harvard Mit Health Sciences & Technology Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Tutte le posizioni attive di James Collins

Precedenti posizioni note di James Collins

SocietàPosizioneFine
░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░ -
░░░░░░░░░ ░░░░ ░░░░░░░ -
Vedi nel dettaglio l'esperienza di James Collins

Formazione di James Collins

College of the Holy Cross (Massachusetts) Undergraduate Degree
University of Oxford Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di James Collins

Relazioni

100 +

Relazioni di 1° grado

25

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa3
FULCRUM THERAPEUTICS, INC.

Health Technology

SYNLOGIC, INC.

Health Technology

SENTI BIOSCIENCES, INC.

Health Technology

Aziende private16

Health Technology

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Finance

Health Technology

Technology Services

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Vedi le connessioni aziendali